Volare Opens €15M Insect Protein Factory
Finnish company Volare completed an industrial insect-protein facility and secured new financing for scaling production.
Alternative protein companies have learned that building a factory is one challenge and operating it economically is another. Finland's Volare has reached an important physical milestone.
What happened
Volare completed its first industrial-scale insect-protein factory in Pori, Finland. The approximately 10,000-square-metre facility cost €15 million to build and is designed for annual production capacity of up to 5,000 tonnes of protein and 2,000 tonnes of oil.
The company also secured €7.1 million in new financing. Its production process uses food-industry byproducts as feedstock to produce ingredients for animal feed.
Volare has emphasised a comparatively capital-efficient industrial model, including the use of a repurposed building and automation. The facility's design capacity is a target, not proof of sustained annual output at those volumes.
Why it matters
Insect protein offers a route to turning low-value organic materials into higher-value feed ingredients. But the sector has been challenged by difficult unit economics, high capital requirements and the need to secure customers at industrial scale.
Volare's construction cost and financing structure are therefore as interesting as its biotechnology. The next test is whether the plant can achieve reliable throughput, consistent product quality and attractive margins once operational.
The bigger picture
The experience of heavily funded insect-protein ventures has made investors more attentive to capital efficiency. Volare represents a practical manufacturing-led approach, where the case depends less on a novel protein narrative and more on industrial execution, feedstock logistics and long-term purchasing agreements. A completed factory is progress, but commercial utilisation will decide the outcome.